Home / Knowledge Centre /
Case study

From FDA Approval to Product Launch

Almac’s Rapid launch service is made possible by robust standardised procedures, which have been developed and put into practice by an experienced multi-disciplinary team of subject matter experts from Project Management, QA, QC, Packaging Design, Production and Logistics. These procedures, in conjunction with strong project management, enables Almac to successfully launch products within 24-48 hours from FDA approval.
This case study details how Intercept Pharmaceuticals partnered with Almac for their US launch of Ocaliva™ and utilised Almac’s rapid launch services to ensure Ocaliva™ was released to Intercept’s distribution warehouse within 48 hours of FDA approval. Download this case study and find out more.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies